Two years clinical experience with color-coded real-time two-dimensional Doppler cardiography

Omoto, Ryozo; Kyo, Shunei; Takamoto, Shinichi; Matsumura, Makoto; Yokote, Yuji; Namekawa, Koroku; Kasai, Chihiro; Yoshikawa, Yusuke; Koyano, Akira

doi:10.1007/978-94-009-4283-7_5

Cited by 2 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These were identified as thebesian veins draining the myocardium, 36 vessels whose flow rates had previously been below the sensitivity thresholds of both angiography and Doppler echocardiography. 37,38 The quantification of myocardial blood flow following intravenous injection of an echo enhancing agent has been described as ''one of the most ambitious targets'' in echocardiography. 4 As recently as 1992, the accurate measurement of coronary blood flow using echocardiography remained an elusive goal; methods at that time were capable of only rough, semiquantitative assessment of myocardial blood flow.…”

Section: Coronary Artery Imagingmentioning

confidence: 99%

Clinical utility of the transpulmonary echo enhancing agent Levovist to improve diagnostic confidence in echocardiography

Nanda

1997

J. Clin. Ultrasound

View full text Add to dashboard Cite

Echo enhancing agents have been used in echocardiography since 1968 for a variety of applications. Until recently, the agents were unable to survive transit through the pulmonary circulation following intravenous injection, and the technique was therefore restricted to investigations of the right side of the heart. Levovist is an echo enhancing agent capable of left heart—and even systemic—enhancement to improve the images obtained with B‐mode and Doppler echocardiography. This agent offers important practical advantages in “routine” echocardiography, particularly in patients in whom image quality is suboptimal or baseline examination fails due to physical limitations. Potential future uses of contrast‐enhanced echocardiography include quantitative analysis of coronary artery flow. © 1997 John Wiley & Sons, Inc. J Clin Ultrasound 25: 411–419, 1997.

show abstract

Section: Coronary Artery Imagingmentioning

confidence: 99%

Clinical utility of the transpulmonary echo enhancing agent Levovist to improve diagnostic confidence in echocardiography

Nanda

1997

J. Clin. Ultrasound

View full text Add to dashboard Cite

show abstract

“…[20][21][22][23] A comb filter (moving target indication filter) can cancel the effects of wall motion to which the transducer is attached. Thus, only the Doppler signals pass through the filter.…”

Section: Introductionmentioning

confidence: 99%

M-Mode Color Doppler Ultrasonic Imaging of Vertical Tongue Movement During Articulatory Movement

Saigusa

Saigusa²,

Aino

et al. 2006

Journal of Voice

View full text Add to dashboard Cite

Two years clinical experience with color-coded real-time two-dimensional Doppler cardiography

Cited by 2 publications

References 8 publications

Clinical utility of the transpulmonary echo enhancing agent Levovist to improve diagnostic confidence in echocardiography

Clinical utility of the transpulmonary echo enhancing agent Levovist to improve diagnostic confidence in echocardiography

M-Mode Color Doppler Ultrasonic Imaging of Vertical Tongue Movement During Articulatory Movement

Contact Info

Product

Resources

About